Drägerwerk AG & Co. KGaA (ETR:DRW3) has received a consensus rating of “Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is €87.60 ($103.06).
DRW3 has been the topic of several analyst reports. Nord/LB set a €103.00 ($121.18) price target on shares of Drägerwerk AG & Co. KGaA and gave the stock a “buy” rating in a report on Thursday, November 5th. Independent Research set a €66.00 ($77.65) price target on shares of Drägerwerk AG & Co. KGaA and gave the stock a “sell” rating in a report on Friday, January 15th. Kepler Capital Markets set a €71.00 ($83.53) price objective on shares of Drägerwerk AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Monday, January 11th. Finally, Warburg Research set a €103.00 ($121.18) price objective on shares of Drägerwerk AG & Co. KGaA and gave the stock a “buy” rating in a research report on Thursday, January 14th.
Drägerwerk AG & Co. KGaA stock traded down €1.90 ($2.24) during midday trading on Tuesday, hitting €64.90 ($76.35). 64,820 shares of the stock were exchanged, compared to its average volume of 33,804. Drägerwerk AG & Co. KGaA has a 52-week low of €47.94 ($56.40) and a 52-week high of €108.50 ($127.65). The stock has a market capitalization of $558.14 million and a price-to-earnings ratio of 46.23. The business’s 50-day moving average price is €67.87 and its 200-day moving average price is €69.35. The company has a quick ratio of 0.91, a current ratio of 1.61 and a debt-to-equity ratio of 15.25.
Drägerwerk AG & Co. KGaA Company Profile
DrÃ¤gerwerk AG & Co KGaA operates as medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.
Further Reading: LIBOR
Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.